KENNETH JIANG: Open Payments
NPI 1841279841 · HOLLISTER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 36 payments from 9 companies in 2025. Trend: 2023 $272 · 2024 $304 · 2025 $767
Food & beverage: $767
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $250 |
| Amgen Inc. | 16 | $247 |
| GlaxoSmithKline, LLC. | 3 | $95 |
| ABBVIE INC. | 2 | $54 |
| Novo Nordisk Inc | 1 | $27 |
| Lilly USA, LLC | 1 | $27 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $26 |
| PFIZER INC. | 1 | $24 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $17 |
Products named: OTEZLA, BREZTRI, TRELEGY ELLIPTA, FARXIGA, VRAYLAR, REPATHA, Rybelsus, MOUNJARO.
Industry payments across CA — which companies pay providers there.
